Lumbar problems have become a prevalent musculoskeletal disease among the general population. According to clinical orthopedic diagnosis and treatment data, the incidence of lumbar disc herniation and lumbar muscle strain among sedentary people exceeds 70%, and the detection rate of straightening of the physiological curvature of the lumbar spine in adolescents is rising year by year.

In the era of health and wellness, TENS (Transcutaneous Electrical Nerve Stimulation), EMS(Electrical Muscle Stimulation), and LED light therapy products have emerged as go-to solutions for pain relief, muscle recovery, and body contouring. However, the market is flooded with low-quality, uncertified devices that make bold claims—“fast-acting pain relief,” “7-day muscle sculpting,” “zero side effects”—yet fail to deliver on their promises. Worse, many uncertified products pose hidden risks, from ineffective stimulation to potential tissue damage. For discerning buyers prioritizing safety and proven efficacy, MDR (EU Medical Device Regulation) and FDA 510(k) certification are not just “optional extras”—they are the definitive benchmarks to separate medical-grade, clinically validated products from ineffective, unsafe alternatives.

In the professional sports arena, victory or defeat often hinges on millisecond differences and the optimal state of muscles. The technological upgrading of sports rehabilitation and physical recovery has long become the core code for professional athletes to maintain their competitiveness.

Introducing OSTO Red Light Therapy Panel: Harnessing 655nm & 855nm multi-spectral LED technology with 4 smart modes for anti-aging, acne treatment, and comprehensive skin rejuvenation. Experience professional light therapy at home.

OSTO's deep dive into EMS technology: revealing how electrical pulses scientifically activate muscle strength and circulation, showcasing professional-grade EMS muscle stimulator applications.

In today's fast-paced world, a "silent epidemic" is quietly affecting the quality of life for hundreds of millions globally—chronic pain. Studies show that if pain lasting more than three months is considered chronic, up to half of all adults may be living with it, with 10-20% experiencing clinically significant levels. In Europe, nearly one-fifth (19%) of adults suffer from long-term moderate to severe pain. This not only severely disrupts their social and work capabilities but also continuously impacts their physical and mental well-being due to inadequate pain management.



Chronic pain is not a single condition but a heterogeneous phenomenon. Its underlying causes are diverse: from nociceptive or neuropathic pain like arthritis and diabetic neuropathy caused by clear peripheral tissue damage, to more complex types such as fibromyalgia and chronic non-specific low back pain. Regardless of the cause, the outcome is the same: it significantly reduces patients' quality of life and places a heavy economic burden on society through decreased productivity, reduced social participation, and increased healthcare resource consumption.